New Paradigms in the Treatment Options for ALL and AML: European Perspective – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists and other health care professionals who diagnose, treat, and manage patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

Commercial Supporter

---

Supported by Pfizer Inc.